EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Next-generation atopic dermatitis treatments based on nanotechnology as an effective and low-side-effect solution

Kamran Ebrahimian, Farnaz Dabbagh Moghaddam, Shir-Mohammad Tavangari, Hanie Razavi, Sajjad Janfaza

Oxford Open Materials Science · 18.01.2026 · 6 (1)

DOI: 10.1093/oxfmat/itag003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oxford Open Materials Science, online erschienen am 19.03.2026. Verfasst von Kamran Ebrahimian und 4 weiteren Autor:innen. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atopic dermatitis (AD) is a chronic inflammatory skin disorder that is characterized by epidermal immune dysregulation, barrier dysfunction, and persistent inflammation. There is no cure for AD yet. Topical treatments often struggle with poor skin absorption, necessitating frequent applications and higher medication doses, which can lead to systemic side effects. In this study, we explore the use of nanotechnology-based topical delivery systems to enhance the therapeutic management of AD. Nanoparticles encapsulating anti-inflammatory drugs enable targeted delivery to the epidermis and upper dermis, where inflammatory processes are most active. This localized release at the site of immune cell infiltration leads to higher local drug concentrations, prolonged skin retention, and reduced systemic exposure. This approach offers several clinical benefits, including a faster therapeutic response, reduced dosing frequency, and improved overall efficacy. Drug delivery represents a promising strategy for optimizing topical AD treatment while minimizing adverse effects.

Zitieren

APA

Ebrahimian, K., Moghaddam, F. D., Tavangari, S., Razavi, H., & Janfaza, S. (2026). Next-generation atopic dermatitis treatments based on nanotechnology as an effective and low-side-effect solution. Oxford Open Materials Science, 6(1). https://doi.org/10.1093/oxfmat/itag003

Vancouver

Ebrahimian K, Moghaddam FD, Tavangari S, Razavi H, Janfaza S. Next-generation atopic dermatitis treatments based on nanotechnology as an effective and low-side-effect solution. Oxford Open Materials Science. 2026;6(1). doi:10.1093/oxfmat/itag003

BibTeX
@article{Ebrahimian2026,
  author = {Ebrahimian, Kamran and Moghaddam, Farnaz Dabbagh and Tavangari, Shir-Mohammad and Razavi, Hanie and Janfaza, Sajjad},
  title = {Next-generation atopic dermatitis treatments based on nanotechnology as an effective and low-side-effect solution},
  journal = {Oxford Open Materials Science},
  year = {2026},
  volume = {6},
  number = {1},
  doi = {10.1093/oxfmat/itag003}
}
Kostenlos starten →